Oratox
NDC 43742-0944, Fucus Vesiculosus, Lymph Node (Suis), Medulla Ossis Suis, Thymus (Suis), Thyroidinum (Suis), Calcarea Muriatica, Iodium, Natrum Fluoratum, Natrum Muriaticum, Selenium Metallicum, Vanadium Metallicum, Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum, Palladium Metallicum, Stannum Metallicum, Titanium Metallicum, Zincum Metallicum, liquid, from Deseret Biologicals, Inc..
- Product NDC
- 43742-0944
- Status
- Listed
- Labeler
- Deseret Biologicals, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43742-0944 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FUCUS VESICULOSUS3 [hp_X]/mL
- SUS SCROFA LYMPH8 [hp_X]/mL
- SUS SCROFA BONE MARROW8 [hp_X]/mL
- SUS SCROFA THYMUS8 [hp_X]/mL
- THYROID8 [hp_X]/mL
- CALCIUM CHLORIDE12 [hp_X]/mL
- IODINE12 [hp_X]/mL
- SODIUM FLUORIDE12 [hp_X]/mL
- SODIUM CHLORIDE12 [hp_X]/mL
- SELENIUM12 [hp_X]/mL
- VANADIUM12 [hp_X]/mL
- SILVER12 [hp_X]/mL
- GOLD12 [hp_X]/mL
- COPPER12 [hp_X]/mL
- EUGENOL12 [hp_X]/mL
- FORMALDEHYDE12 [hp_X]/mL
- LIDOCAINE12 [hp_X]/mL
- MERCURIUS SOLUBILIS12 [hp_X]/mL
- MOLYBDENUM12 [hp_X]/mL
- NICKEL12 [hp_X]/mL
- PALLADIUM12 [hp_X]/mL
- TIN12 [hp_X]/mL
- TITANIUM12 [hp_X]/mL
- ZINC12 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]; Increased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Inhibit Ovum Fertilization [PE]; Local Anesthesia [PE]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43742-0944-1 | 43742094401 | 30 mL in 1 BOTTLE, DROPPER (43742-0944-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43742-0944 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43742-0944 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43742-0944. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.